转移性皮肤鳞状细胞癌累及腮腺时行择区性颈淋巴结清扫术:系统评价与荟萃分析
该系统评价与荟萃分析检索了Medline和Embase,纳入17篇文献,共874例无临床颈淋巴结转移证据的腮腺转移性皮肤鳞状细胞癌患者接受择区性颈淋巴结清扫术,随机效应模型显示隐匿性颈淋巴结病变总患病率为22.5%(95%CI 18.9-26.0),作者推荐该组患者行择区性颈淋巴结清扫术。
要点
- 腮腺转移性皮肤鳞状细胞癌患者隐匿性颈淋巴结病变患病率为22.5%(95%CI 18.9-26.0)。
- 共17篇文献、874例无临床颈淋巴结转移证据的患者接受择区性颈淋巴结清扫术。
- 作者推荐该组患者行择区性颈淋巴结清扫术。
核心结论
- 腮腺转移性皮肤鳞状细胞癌患者隐匿性颈淋巴结病变患病率高,作者推荐该组患者行择区性颈淋巴结清扫术。
研究设计与样本
- 系统评价与荟萃分析,检索Medline和Embase,共鉴定89篇文献,17篇符合纳入标准。
- 共874例腮腺转移性皮肤鳞状细胞癌且无临床明显颈淋巴结病变的患者接受择区性颈淋巴结清扫术。
主要发现
- 随机效应模型显示,隐匿性颈淋巴结病变总患病率为22.5%(95%CI 18.9-26.0)。
关键数值与推荐
- 作者推荐对腮腺转移性皮肤鳞状细胞癌且无临床明显颈淋巴结病变的患者行择区性颈淋巴结清扫术。
临床怎么用
- 作者推荐对腮腺转移性皮肤鳞状细胞癌且无临床明显颈淋巴结病变的患者行择区性颈淋巴结清扫术。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Current management of metastatic cutaneous squamous cell carcinoma (CSCC) to the parotid is surgical excision and postoperative radiotherapy. In the node-negative neck, there is debate about the role of elective neck dissection (END), irradiation or observation. This systematic review assesses the prevalence of occult cervical disease and the evidence for END. A literature search was performed using Medline and Embase. All papers describing management of the neck in metastatic CSCC to the parotid were assessed for inclusion. Eighty-nine papers were identified and 17 met inclusion criteria. A total of 874 ENDs were performed in 874 patients with metastatic CSCC to the parotid with no clinically evident cervical disease. The overall prevalence of occult disease in a random effects model was 22.5% (95% confidence intervals 18.9-26.0). The prevalence of occult cervical disease in metastatic CSCC to the parotid is high. END is recommended in this patient group.
引用
- Rotman A, Kerr SJ, Giddings CEB, et al. Elective neck dissection in metastatic cutaneous squamous cell carcinoma to the parotid gland: A systematic review and meta-analysis. Head Neck. 2018. PMID: 30536662. doi:10.1002/hed.25561
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。